30.11.2017 - In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)